ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liposomes Nanoparticle Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-32G13065
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Liposomes Nanoparticle Drugs Market Research Report 2023
BUY CHAPTERS

Global Liposomes Nanoparticle Drugs Market Research Report 2025

Code: QYRE-Auto-32G13065
Report
May 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
TEVA
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen S A
Sayre Therapeutics
JAZZ
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences

Liposomes Nanoparticle Drugs Market Size

The global market for Liposomes Nanoparticle Drugs was valued at US$ 6064 million in the year 2024 and is projected to reach a revised size of US$ 11710 million by 2031, growing at a CAGR of 10.0% during the forecast period.

Liposomes Nanoparticle Drugs Market

Liposomes Nanoparticle Drugs Market

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
The liposomes nanoparticle drugs market is driven by the increasing demand for targeted drug delivery systems and the potential of liposomes to improve therapeutic efficacy. Liposomes are nanoscale vesicles composed of lipid bilayers that can encapsulate various drugs and deliver them to specific target sites in the body. This targeted drug delivery offers benefits such as reduced side effects, improved drug bioavailability, and enhanced therapeutic outcomes. As the prevalence of chronic diseases rises and the need for personalized medicine grows, liposomes nanoparticle drugs gain popularity in the pharmaceutical industry. Moreover, advancements in nanotechnology and biopharmaceutical research have led to the development of innovative liposomal formulations for a wide range of diseases. However, the market also faces challenges, including the high costs associated with liposomal drug development and production. Additionally, regulatory complexities related to nanomedicines and the need for comprehensive safety evaluations pose obstacles to market growth. To leverage the market"s potential fully, manufacturers need to focus on cost-effectiveness, quality assurance, and robust clinical data to gain regulatory approvals and establish the efficacy and safety of liposomes nanoparticle drugs.
This report aims to provide a comprehensive presentation of the global market for Liposomes Nanoparticle Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes Nanoparticle Drugs.
The Liposomes Nanoparticle Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomes Nanoparticle Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomes Nanoparticle Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Liposomes Nanoparticle Drugs Market Report

Report Metric Details
Report Name Liposomes Nanoparticle Drugs Market
Accounted market size in year US$ 6064 million
Forecasted market size in 2031 US$ 11710 million
CAGR 10.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma, Pacira, Luye Pharma, Leadiant Biosciences, Ipsen, Sayre Therapeutics, Jazz, Alnylam, Bausch Health, Acrotech Biopharma, Takeda, Chiesi Farmaceutici, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Liposomes Nanoparticle Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Liposomes Nanoparticle Drugs Market growing?

Ans: The Liposomes Nanoparticle Drugs Market witnessing a CAGR of 10.0% during the forecast period 2025-2031.

What is the Liposomes Nanoparticle Drugs Market size in 2031?

Ans: The Liposomes Nanoparticle Drugs Market size in 2031 will be US$ 11710 million.

Who are the main players in the Liposomes Nanoparticle Drugs Market report?

Ans: The main players in the Liposomes Nanoparticle Drugs Market are Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma, Pacira, Luye Pharma, Leadiant Biosciences, Ipsen, Sayre Therapeutics, Jazz, Alnylam, Bausch Health, Acrotech Biopharma, Takeda, Chiesi Farmaceutici, Gilead Sciences

What are the Application segmentation covered in the Liposomes Nanoparticle Drugs Market report?

Ans: The Applications covered in the Liposomes Nanoparticle Drugs Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Liposomes Nanoparticle Drugs Market report?

Ans: The Types covered in the Liposomes Nanoparticle Drugs Market report are Liposomes Drugs, Lipid Nanoparticle Drugs

Recommended Reports

Liposomal Technologies

Nanoparticle Delivery

Lipid-Based Systems

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomes Nanoparticle Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liposomes Drugs
1.2.3 Lipid Nanoparticle Drugs
1.3 Market by Application
1.3.1 Global Liposomes Nanoparticle Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomes Nanoparticle Drugs Market Perspective (2020-2031)
2.2 Global Liposomes Nanoparticle Drugs Growth Trends by Region
2.2.1 Global Liposomes Nanoparticle Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposomes Nanoparticle Drugs Historic Market Size by Region (2020-2025)
2.2.3 Liposomes Nanoparticle Drugs Forecasted Market Size by Region (2026-2031)
2.3 Liposomes Nanoparticle Drugs Market Dynamics
2.3.1 Liposomes Nanoparticle Drugs Industry Trends
2.3.2 Liposomes Nanoparticle Drugs Market Drivers
2.3.3 Liposomes Nanoparticle Drugs Market Challenges
2.3.4 Liposomes Nanoparticle Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposomes Nanoparticle Drugs Players by Revenue
3.1.1 Global Top Liposomes Nanoparticle Drugs Players by Revenue (2020-2025)
3.1.2 Global Liposomes Nanoparticle Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Liposomes Nanoparticle Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposomes Nanoparticle Drugs Revenue
3.4 Global Liposomes Nanoparticle Drugs Market Concentration Ratio
3.4.1 Global Liposomes Nanoparticle Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomes Nanoparticle Drugs Revenue in 2024
3.5 Global Key Players of Liposomes Nanoparticle Drugs Head office and Area Served
3.6 Global Key Players of Liposomes Nanoparticle Drugs, Product and Application
3.7 Global Key Players of Liposomes Nanoparticle Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomes Nanoparticle Drugs Breakdown Data by Type
4.1 Global Liposomes Nanoparticle Drugs Historic Market Size by Type (2020-2025)
4.2 Global Liposomes Nanoparticle Drugs Forecasted Market Size by Type (2026-2031)
5 Liposomes Nanoparticle Drugs Breakdown Data by Application
5.1 Global Liposomes Nanoparticle Drugs Historic Market Size by Application (2020-2025)
5.2 Global Liposomes Nanoparticle Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposomes Nanoparticle Drugs Market Size (2020-2031)
6.2 North America Liposomes Nanoparticle Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposomes Nanoparticle Drugs Market Size by Country (2020-2025)
6.4 North America Liposomes Nanoparticle Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposomes Nanoparticle Drugs Market Size (2020-2031)
7.2 Europe Liposomes Nanoparticle Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposomes Nanoparticle Drugs Market Size by Country (2020-2025)
7.4 Europe Liposomes Nanoparticle Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposomes Nanoparticle Drugs Market Size (2020-2031)
8.2 Asia-Pacific Liposomes Nanoparticle Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposomes Nanoparticle Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposomes Nanoparticle Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposomes Nanoparticle Drugs Market Size (2020-2031)
9.2 Latin America Liposomes Nanoparticle Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposomes Nanoparticle Drugs Market Size by Country (2020-2025)
9.4 Latin America Liposomes Nanoparticle Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposomes Nanoparticle Drugs Market Size (2020-2031)
10.2 Middle East & Africa Liposomes Nanoparticle Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposomes Nanoparticle Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposomes Nanoparticle Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Liposomes Nanoparticle Drugs Introduction
11.1.4 Johnson & Johnson Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Details
11.2.2 Sun Pharmaceutical Business Overview
11.2.3 Sun Pharmaceutical Liposomes Nanoparticle Drugs Introduction
11.2.4 Sun Pharmaceutical Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.2.5 Sun Pharmaceutical Recent Development
11.3 CSPC
11.3.1 CSPC Company Details
11.3.2 CSPC Business Overview
11.3.3 CSPC Liposomes Nanoparticle Drugs Introduction
11.3.4 CSPC Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.3.5 CSPC Recent Development
11.4 Kinyond
11.4.1 Kinyond Company Details
11.4.2 Kinyond Business Overview
11.4.3 Kinyond Liposomes Nanoparticle Drugs Introduction
11.4.4 Kinyond Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.4.5 Kinyond Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Liposomes Nanoparticle Drugs Introduction
11.5.4 Teva Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.5.5 Teva Recent Development
11.6 Fudan-Zhangjiang
11.6.1 Fudan-Zhangjiang Company Details
11.6.2 Fudan-Zhangjiang Business Overview
11.6.3 Fudan-Zhangjiang Liposomes Nanoparticle Drugs Introduction
11.6.4 Fudan-Zhangjiang Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.6.5 Fudan-Zhangjiang Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Details
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila Liposomes Nanoparticle Drugs Introduction
11.7.4 Zydus Cadila Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.7.5 Zydus Cadila Recent Development
11.8 TTY Biopharma
11.8.1 TTY Biopharma Company Details
11.8.2 TTY Biopharma Business Overview
11.8.3 TTY Biopharma Liposomes Nanoparticle Drugs Introduction
11.8.4 TTY Biopharma Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.8.5 TTY Biopharma Recent Development
11.9 Pacira
11.9.1 Pacira Company Details
11.9.2 Pacira Business Overview
11.9.3 Pacira Liposomes Nanoparticle Drugs Introduction
11.9.4 Pacira Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.9.5 Pacira Recent Development
11.10 Luye Pharma
11.10.1 Luye Pharma Company Details
11.10.2 Luye Pharma Business Overview
11.10.3 Luye Pharma Liposomes Nanoparticle Drugs Introduction
11.10.4 Luye Pharma Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.10.5 Luye Pharma Recent Development
11.11 Leadiant Biosciences
11.11.1 Leadiant Biosciences Company Details
11.11.2 Leadiant Biosciences Business Overview
11.11.3 Leadiant Biosciences Liposomes Nanoparticle Drugs Introduction
11.11.4 Leadiant Biosciences Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.11.5 Leadiant Biosciences Recent Development
11.12 Ipsen
11.12.1 Ipsen Company Details
11.12.2 Ipsen Business Overview
11.12.3 Ipsen Liposomes Nanoparticle Drugs Introduction
11.12.4 Ipsen Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.12.5 Ipsen Recent Development
11.13 Sayre Therapeutics
11.13.1 Sayre Therapeutics Company Details
11.13.2 Sayre Therapeutics Business Overview
11.13.3 Sayre Therapeutics Liposomes Nanoparticle Drugs Introduction
11.13.4 Sayre Therapeutics Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.13.5 Sayre Therapeutics Recent Development
11.14 Jazz
11.14.1 Jazz Company Details
11.14.2 Jazz Business Overview
11.14.3 Jazz Liposomes Nanoparticle Drugs Introduction
11.14.4 Jazz Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.14.5 Jazz Recent Development
11.15 Alnylam
11.15.1 Alnylam Company Details
11.15.2 Alnylam Business Overview
11.15.3 Alnylam Liposomes Nanoparticle Drugs Introduction
11.15.4 Alnylam Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.15.5 Alnylam Recent Development
11.16 Bausch Health
11.16.1 Bausch Health Company Details
11.16.2 Bausch Health Business Overview
11.16.3 Bausch Health Liposomes Nanoparticle Drugs Introduction
11.16.4 Bausch Health Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.16.5 Bausch Health Recent Development
11.17 Acrotech Biopharma
11.17.1 Acrotech Biopharma Company Details
11.17.2 Acrotech Biopharma Business Overview
11.17.3 Acrotech Biopharma Liposomes Nanoparticle Drugs Introduction
11.17.4 Acrotech Biopharma Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.17.5 Acrotech Biopharma Recent Development
11.18 Takeda
11.18.1 Takeda Company Details
11.18.2 Takeda Business Overview
11.18.3 Takeda Liposomes Nanoparticle Drugs Introduction
11.18.4 Takeda Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.18.5 Takeda Recent Development
11.19 Chiesi Farmaceutici
11.19.1 Chiesi Farmaceutici Company Details
11.19.2 Chiesi Farmaceutici Business Overview
11.19.3 Chiesi Farmaceutici Liposomes Nanoparticle Drugs Introduction
11.19.4 Chiesi Farmaceutici Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.19.5 Chiesi Farmaceutici Recent Development
11.20 Gilead Sciences
11.20.1 Gilead Sciences Company Details
11.20.2 Gilead Sciences Business Overview
11.20.3 Gilead Sciences Liposomes Nanoparticle Drugs Introduction
11.20.4 Gilead Sciences Revenue in Liposomes Nanoparticle Drugs Business (2020-2025)
11.20.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
TEVA
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen S A
Sayre Therapeutics
JAZZ
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
List of Tables
 Table 1. Global Liposomes Nanoparticle Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Liposomes Drugs
 Table 3. Key Players of Lipid Nanoparticle Drugs
 Table 4. Global Liposomes Nanoparticle Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Liposomes Nanoparticle Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Liposomes Nanoparticle Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Liposomes Nanoparticle Drugs Market Share by Region (2020-2025)
 Table 8. Global Liposomes Nanoparticle Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Liposomes Nanoparticle Drugs Market Share by Region (2026-2031)
 Table 10. Liposomes Nanoparticle Drugs Market Trends
 Table 11. Liposomes Nanoparticle Drugs Market Drivers
 Table 12. Liposomes Nanoparticle Drugs Market Challenges
 Table 13. Liposomes Nanoparticle Drugs Market Restraints
 Table 14. Global Liposomes Nanoparticle Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Liposomes Nanoparticle Drugs Market Share by Players (2020-2025)
 Table 16. Global Top Liposomes Nanoparticle Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes Nanoparticle Drugs as of 2024)
 Table 17. Ranking of Global Top Liposomes Nanoparticle Drugs Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Liposomes Nanoparticle Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Liposomes Nanoparticle Drugs, Headquarters and Area Served
 Table 20. Global Key Players of Liposomes Nanoparticle Drugs, Product and Application
 Table 21. Global Key Players of Liposomes Nanoparticle Drugs, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Liposomes Nanoparticle Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Liposomes Nanoparticle Drugs Revenue Market Share by Type (2020-2025)
 Table 25. Global Liposomes Nanoparticle Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Liposomes Nanoparticle Drugs Revenue Market Share by Type (2026-2031)
 Table 27. Global Liposomes Nanoparticle Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Liposomes Nanoparticle Drugs Revenue Market Share by Application (2020-2025)
 Table 29. Global Liposomes Nanoparticle Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Liposomes Nanoparticle Drugs Revenue Market Share by Application (2026-2031)
 Table 31. North America Liposomes Nanoparticle Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Liposomes Nanoparticle Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Liposomes Nanoparticle Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Liposomes Nanoparticle Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Liposomes Nanoparticle Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Liposomes Nanoparticle Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Liposomes Nanoparticle Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Liposomes Nanoparticle Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Liposomes Nanoparticle Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Liposomes Nanoparticle Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Liposomes Nanoparticle Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Liposomes Nanoparticle Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Liposomes Nanoparticle Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Liposomes Nanoparticle Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Johnson & Johnson Company Details
 Table 47. Johnson & Johnson Business Overview
 Table 48. Johnson & Johnson Liposomes Nanoparticle Drugs Product
 Table 49. Johnson & Johnson Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 50. Johnson & Johnson Recent Development
 Table 51. Sun Pharmaceutical Company Details
 Table 52. Sun Pharmaceutical Business Overview
 Table 53. Sun Pharmaceutical Liposomes Nanoparticle Drugs Product
 Table 54. Sun Pharmaceutical Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 55. Sun Pharmaceutical Recent Development
 Table 56. CSPC Company Details
 Table 57. CSPC Business Overview
 Table 58. CSPC Liposomes Nanoparticle Drugs Product
 Table 59. CSPC Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 60. CSPC Recent Development
 Table 61. Kinyond Company Details
 Table 62. Kinyond Business Overview
 Table 63. Kinyond Liposomes Nanoparticle Drugs Product
 Table 64. Kinyond Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 65. Kinyond Recent Development
 Table 66. Teva Company Details
 Table 67. Teva Business Overview
 Table 68. Teva Liposomes Nanoparticle Drugs Product
 Table 69. Teva Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 70. Teva Recent Development
 Table 71. Fudan-Zhangjiang Company Details
 Table 72. Fudan-Zhangjiang Business Overview
 Table 73. Fudan-Zhangjiang Liposomes Nanoparticle Drugs Product
 Table 74. Fudan-Zhangjiang Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 75. Fudan-Zhangjiang Recent Development
 Table 76. Zydus Cadila Company Details
 Table 77. Zydus Cadila Business Overview
 Table 78. Zydus Cadila Liposomes Nanoparticle Drugs Product
 Table 79. Zydus Cadila Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 80. Zydus Cadila Recent Development
 Table 81. TTY Biopharma Company Details
 Table 82. TTY Biopharma Business Overview
 Table 83. TTY Biopharma Liposomes Nanoparticle Drugs Product
 Table 84. TTY Biopharma Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 85. TTY Biopharma Recent Development
 Table 86. Pacira Company Details
 Table 87. Pacira Business Overview
 Table 88. Pacira Liposomes Nanoparticle Drugs Product
 Table 89. Pacira Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 90. Pacira Recent Development
 Table 91. Luye Pharma Company Details
 Table 92. Luye Pharma Business Overview
 Table 93. Luye Pharma Liposomes Nanoparticle Drugs Product
 Table 94. Luye Pharma Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 95. Luye Pharma Recent Development
 Table 96. Leadiant Biosciences Company Details
 Table 97. Leadiant Biosciences Business Overview
 Table 98. Leadiant Biosciences Liposomes Nanoparticle Drugs Product
 Table 99. Leadiant Biosciences Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 100. Leadiant Biosciences Recent Development
 Table 101. Ipsen Company Details
 Table 102. Ipsen Business Overview
 Table 103. Ipsen Liposomes Nanoparticle Drugs Product
 Table 104. Ipsen Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 105. Ipsen Recent Development
 Table 106. Sayre Therapeutics Company Details
 Table 107. Sayre Therapeutics Business Overview
 Table 108. Sayre Therapeutics Liposomes Nanoparticle Drugs Product
 Table 109. Sayre Therapeutics Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 110. Sayre Therapeutics Recent Development
 Table 111. Jazz Company Details
 Table 112. Jazz Business Overview
 Table 113. Jazz Liposomes Nanoparticle Drugs Product
 Table 114. Jazz Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 115. Jazz Recent Development
 Table 116. Alnylam Company Details
 Table 117. Alnylam Business Overview
 Table 118. Alnylam Liposomes Nanoparticle Drugs Product
 Table 119. Alnylam Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 120. Alnylam Recent Development
 Table 121. Bausch Health Company Details
 Table 122. Bausch Health Business Overview
 Table 123. Bausch Health Liposomes Nanoparticle Drugs Product
 Table 124. Bausch Health Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 125. Bausch Health Recent Development
 Table 126. Acrotech Biopharma Company Details
 Table 127. Acrotech Biopharma Business Overview
 Table 128. Acrotech Biopharma Liposomes Nanoparticle Drugs Product
 Table 129. Acrotech Biopharma Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 130. Acrotech Biopharma Recent Development
 Table 131. Takeda Company Details
 Table 132. Takeda Business Overview
 Table 133. Takeda Liposomes Nanoparticle Drugs Product
 Table 134. Takeda Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 135. Takeda Recent Development
 Table 136. Chiesi Farmaceutici Company Details
 Table 137. Chiesi Farmaceutici Business Overview
 Table 138. Chiesi Farmaceutici Liposomes Nanoparticle Drugs Product
 Table 139. Chiesi Farmaceutici Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 140. Chiesi Farmaceutici Recent Development
 Table 141. Gilead Sciences Company Details
 Table 142. Gilead Sciences Business Overview
 Table 143. Gilead Sciences Liposomes Nanoparticle Drugs Product
 Table 144. Gilead Sciences Revenue in Liposomes Nanoparticle Drugs Business (2020-2025) & (US$ Million)
 Table 145. Gilead Sciences Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Liposomes Nanoparticle Drugs Picture
 Figure 2. Global Liposomes Nanoparticle Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Liposomes Nanoparticle Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Liposomes Drugs Features
 Figure 5. Lipid Nanoparticle Drugs Features
 Figure 6. Global Liposomes Nanoparticle Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Liposomes Nanoparticle Drugs Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Other Case Studies
 Figure 11. Liposomes Nanoparticle Drugs Report Years Considered
 Figure 12. Global Liposomes Nanoparticle Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Liposomes Nanoparticle Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Liposomes Nanoparticle Drugs Market Share by Region: 2024 VS 2031
 Figure 15. Global Liposomes Nanoparticle Drugs Market Share by Players in 2024
 Figure 16. Global Top Liposomes Nanoparticle Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes Nanoparticle Drugs as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Liposomes Nanoparticle Drugs Revenue in 2024
 Figure 18. North America Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Liposomes Nanoparticle Drugs Market Share by Country (2020-2031)
 Figure 20. United States Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Liposomes Nanoparticle Drugs Market Share by Country (2020-2031)
 Figure 24. Germany Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Liposomes Nanoparticle Drugs Market Share by Region (2020-2031)
 Figure 32. China Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Liposomes Nanoparticle Drugs Market Share by Country (2020-2031)
 Figure 40. Mexico Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Liposomes Nanoparticle Drugs Market Share by Country (2020-2031)
 Figure 44. Turkey Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Liposomes Nanoparticle Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Johnson & Johnson Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 48. Sun Pharmaceutical Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 49. CSPC Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 50. Kinyond Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 51. Teva Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 52. Fudan-Zhangjiang Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 53. Zydus Cadila Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 54. TTY Biopharma Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 55. Pacira Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 56. Luye Pharma Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 57. Leadiant Biosciences Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 58. Ipsen Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 59. Sayre Therapeutics Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 60. Jazz Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 61. Alnylam Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 62. Bausch Health Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 63. Acrotech Biopharma Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 64. Takeda Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 65. Chiesi Farmaceutici Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 66. Gilead Sciences Revenue Growth Rate in Liposomes Nanoparticle Drugs Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nanotechnology in Targeted Drug Delivery Market Research Report 2024
Global Nano based Drug Delivery System Market Research Report 2024
Global Nanotechnology based Drug Delivery Systems Market Research Report 2024
Liposome FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nanoparticle Mediated Delivery Market Research Report 2025
Liposome and Lipid Nanoparticle FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nanoparticle Drug Delivery System Market Research Report 2024
Liposomal Drug delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Contract Manufacturing Market Research Report 2024
Global Nanoparticle Carriers Market Research Report 2024
Global Targeted Drug Delivery System Market Research Report 2025
Global Liposome Drug Delivery Market Insights Forecast to 2030
Global Nanoparticle Drug Delivery Systems Market Research Report 2024
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Research Report 2024

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions